The exploration of technological diversity and the geographic localization of innovation, Small Business Economics, vol.9, issue.1, pp.21-31, 1997. ,
DOI : 10.1023/A:1007995512597
Company-scientist locational links: the case of biotechnology, American Economic Review, vol.86, issue.3, pp.641-652, 1996. ,
Knowledge spillovers in biotechnology: sources and incentives, Journal of Evolutionary Economics, vol.9, issue.1, pp.97-107, 1999. ,
DOI : 10.1007/s001910050076
Editor's introduction: building and deploying scientific and technical capital' Research Policy, pp.565-568, 2004. ,
7. Coming from good stock: Career histories and new venture formation, Social Structure and Organizations Revisited, vol.19, pp.229-262, 2002. ,
DOI : 10.1016/S0733-558X(02)19007-0
URL : https://hal.archives-ouvertes.fr/insu-00375898
Financing and advising: optimal financial contracts with venture capitalists' The Journal of Finance, pp.2059-2086, 2003. ,
Exporting the Silicon Valley to Europe: how useful is comparative institutional theory Innovation, Science, and Institutional Change. A research handbook, pp.482-504, 2006. ,
How do technology clusters emerge and become sustainable?, Research Policy, vol.36, issue.4, pp.438-455, 2007. ,
DOI : 10.1016/j.respol.2007.02.018
The French National System of Innovation (ed) National Innovation Systems, 1993. ,
Beyond borders, Global Biotechnology report, 2005. ,
Panorama 2006 of the biotechnologies industry in France, 2007. ,
Technology policy and economic performance: lessons from JapanNational Systems of Innovation in historical perspective, Cambrige Journal of Economics, vol.19, pp.5-24, 1987. ,
The product market and the market for ???ideas???: commercialization strategies for technology entrepreneurs, Research Policy, vol.32, issue.2, pp.333-350, 2003. ,
DOI : 10.1016/S0048-7333(02)00103-8
Pharmaceutical Firms and the Transition to Biotechnology: A Study in Strategic Innovation, Business History Review, vol.37, issue.02, pp.250-278, 1998. ,
DOI : 10.1016/S0048-7333(97)00017-6
National institutions, public???private knowledge flows, and innovation performance: A comparative study of the biotechnology industry in the US and France, Research Policy, vol.35, issue.7, pp.1052-1068, 2006. ,
DOI : 10.1016/j.respol.2006.05.005
Entrepreneurial Spawning: Public Corporations and the Genesis of New Ventures, 1986 to 1999, The Journal of Finance, vol.57, issue.2, pp.577-614, 1986. ,
DOI : 10.1111/0022-1082.00483
Venture capital and the professionalization of start-up Firms: empirical evidence' The Journal of Finance, pp.169-197, 2002. ,
Innovation and Entrepreneurship in Japan: Politics, Organizations and High Technology Firms, 2005. ,
DOI : 10.1017/CBO9780511488702
Evry's Genopole, France' a case study for the EU Eurolabs project, EU DG research, 2001. ,
the Kobe bio-cluster, Japan' report to the IBRI, 2007. ,
Assessing the Contribution of Venture Capital to Innovation, The RAND Journal of Economics, vol.31, issue.4, pp.674-692, 2000. ,
DOI : 10.2307/2696354
Autarkic drug discovery in Japanese pharmaceutical companies: insights into national differences in industrial innovation, Research Policy, vol.32, issue.10, pp.1805-1827, 2003. ,
DOI : 10.1016/S0048-7333(03)00062-3
Bridging Islands. Venture companies and the future of Japanese and American Industry, 2007. ,
Innovation, acteurs, organisations : les ingénieurs et la dynamique de l'entreprise' Working Paper , LEST-CNRS, 1992. ,
Rethinking the public sector: idiosyncrasies of biotechnology commercialisation as motors of national R-D reform in Germany and Japan' Research Policy, pp.6-7, 2004. ,
The Control of Technology Alliances: An Empirical Analysis of the Biotechnology Industry, The Journal of Industrial Economics, vol.46, issue.2, pp.125-156, 1998. ,
DOI : 10.1111/1467-6451.00066
Innovation and market structure in the dynamics of the pharmaceutical industry and biotechnology: towards a history-friendly model, Industrial and Corporate Change, vol.11, issue.4, pp.667-703, 2002. ,
DOI : 10.1093/icc/11.4.667
Development of SMEs and heterogeneity of trajectories : the case of biotechnology in France' Research Policy, pp.621-638, 2003. ,
Spin-offs from public research: trends and outlook' STI-Review, pp.165-172, 2001. ,
The role of academic inventors in entrepreneurial firms: sharing the laboratory life' Research Policy, pp.643-659, 2004. ,
Can Science be a business? Lessons from Biotech, Harvard Business Review, vol.84, issue.10, pp.114-125, 2006. ,
Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology, Administrative Science Quarterly, vol.41, issue.1, pp.116-145, 1996. ,
DOI : 10.2307/2393988
Academic entrepreneurship. University spinoffs ans wealth creation, 2004. ,
Bringing individuals back in: the effects of career experience on new firm founding' Industrial and Corporate Change, pp.519-543, 2003. ,
Intellectual human capital and the birth of US biotechnology entreprises, American Economic Review, vol.88, issue.1, pp.290-306, 1998. ,
Commercializing Knowledge: University Science, Knowledge Capture, and Firm Performance in Biotechnology, Management Science, vol.48, issue.1, pp.138-153, 2002. ,
DOI : 10.1287/mnsc.48.1.138.14274